Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02715804
Recruitment Status : Active, not recruiting
First Posted : March 22, 2016
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Halozyme Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 30, 2019
  Estimated Study Completion Date : December 31, 2019